Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Mar;13(1):3-4.
doi: 10.1177/1753495X20914967. Epub 2020 Mar 26.

Ondansetron for nausea and vomiting in pregnancy: re-evaluating the teratogenic risk

Affiliations
Editorial

Ondansetron for nausea and vomiting in pregnancy: re-evaluating the teratogenic risk

Louise A Michie et al. Obstet Med. 2020 Mar.
No abstract available

PubMed Disclaimer

References

    1. Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol 2013; 20: e171–e183. - PubMed
    1. Christodoulou-Smith J, et al. Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum. J Matern Fetal Neonatal Med 2011; 24: 1307–1311. - PMC - PubMed
    1. Fiaschi L, et al. Assessment of discharge treatment prescribed to women admitted to hospital for hyperemesis gravidarum. Int J Clin Pract 2019; 73: e13261. - PubMed
    1. European Medicines Agency. PRAC recommendations on safety signals. Pharmacovigilance Risk Assessment Committee, https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmac... (2019, accessed 7 March 2020).
    1. Huybrechts KF, et al. Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring. JAMA 2018; 320: 2429–2437. - PMC - PubMed

Publication types

LinkOut - more resources